<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04658784</url>
  </required_header>
  <id_info>
    <org_study_id>#04-20-01</org_study_id>
    <nct_id>NCT04658784</nct_id>
  </id_info>
  <brief_title>Barbed Suture Versus Non-Barbed Suture for Posterior Colporrhaphy</brief_title>
  <official_title>Barbed Suture Versus Non-Barbed Suture for Posterior Colporrhaphy: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atrium Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atrium Health</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this randomized clinical trial is to compare barbed suture versus non-barbed&#xD;
      suture at the time of posterior repair on postoperative pain scores as measured by a visual&#xD;
      analog scale (VAS) at 6 weeks.&#xD;
&#xD;
      Study participants are randomized to use of barbed suture (2-0 V-Loc 90TM, Medtronic) or&#xD;
      non-barbed suture (2-0 Polydioxanone, PDSÂ® EthiconTM) in a standardized technique for&#xD;
      posterior colporrhaphy at the time of posterior repair.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pelvic organ prolapse (POP) is a growing concern for the aging female population, and&#xD;
      symptomatic women often require surgical intervention. Approximately 200,000 surgical&#xD;
      procedures for POP are performed annually in the United States. This number is anticipated to&#xD;
      increase with the growth in the aging population.1 Surgical prolapse repairs are often&#xD;
      categorized into either mesh augmented or native tissue repairs. During a native tissue&#xD;
      repair, the surgeon uses a woman's natural tissue to repair the prolapse without augmenting&#xD;
      the repair with synthetic mesh.&#xD;
&#xD;
      Women often have post-operative pain with native tissue posterior colporrhaphy. Native tissue&#xD;
      posterior repairs are performed to address symptomatic posterior compartment prolapse,&#xD;
      defects in the rectovaginal fibromuscularis, and/or a widened genital hiatus. This type of&#xD;
      repair may improve obstructed defecatory dysfunction and bulge symptoms, but can be&#xD;
      associated with postoperative pelvic pain and dyspareunia. Paraiso et al evaluated three&#xD;
      surgical techniques for posterior colporrhaphy (site-specific, midline plication, and porcine&#xD;
      graft) and found no difference in overall symptom improvement, quality of life, and&#xD;
      post-operative sexual function. Regardless of the technique used, a posterior colporrhaphy&#xD;
      can cause considerable postoperative pain and can contribute to de novo dyspareunia in 9-20%&#xD;
      of women. Most studies evaluating pain after posterior colporrhaphy tend to focus on various&#xD;
      methods of analgesia and surgical technique rather than the suture materials used.&#xD;
&#xD;
      Suture choice may contribute to postoperative pain at the time of posterior colporrhaphy.&#xD;
      There are few studies evaluating suture in the posterior compartment with no defined standard&#xD;
      suture material for posterior colporrhaphy. Available studies, when comparing subjective&#xD;
      bulge and quality of life outcomes, do not demonstrate superiority of one suture type over&#xD;
      the other. Delayed absorbable suture has the benefit of retaining tensile strength for&#xD;
      approximately 3 months. Delayed absorbable suture material itself, however, can remain in&#xD;
      place for up to 8 months. These properties may decrease postoperative pain by decreasing knot&#xD;
      burden. Barbed suture has been successfully applied to vaginal cuff closure, myomectomy,&#xD;
      sacrocolpopexy mesh attachment, and closure of bowel and bladder injuries with demonstrated&#xD;
      reduced operative times. To date, no studies have evaluated the impact of barbed suture on&#xD;
      postoperative pain or surgical time after posterior colporrhaphy.&#xD;
&#xD;
      The primary objective for this study is to compare delayed absorbable barbed suture versus&#xD;
      non-barbed delayed absorbable suture at the time of posterior repair on post-operative&#xD;
      posterior compartment pain scores, as measured by the Visual Analog Scale (VAS), at 6 weeks&#xD;
&#xD;
      Secondary objectives include a comparison of VAS pain scores in the posterior compartment at&#xD;
      6-months, evaluation of operative time for posterior repair in minutes, evaluation of suture&#xD;
      burden and pelvic pain on examination of the posterior compartment, evaluation of pain versus&#xD;
      the length of a repair, evaluation of postoperative patient quality of life (QoL) using&#xD;
      series of standardized questionnaires, evaluation of suture cost, and a comparison of&#xD;
      anatomical and surgical failure in the posterior compartment.&#xD;
&#xD;
      Participants will be approached for participation preoperatively. Baseline demographic data&#xD;
      will be abstracted from the medical record. A baseline Pelvic Organ Prolapse Quantification&#xD;
      (POP-Q) and pelvic myofascial exam will be performed. Baseline VAS and validated&#xD;
      questionnaires: Pelvic Floor Distress Inventory-20 (PFDI-20) sub-scales Colorectal-Anal&#xD;
      Distress Inventory-8 (CRADI-8) and Pelvic Organ Prolapse Distress Inventory-6 (POPDI-6) and&#xD;
      Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire- 12 (PISQ-12 )will be&#xD;
      completed. Participants will be randomized in the operating room after posterior vaginal&#xD;
      dissection to either barbed or non-barbed suture in a standardized technique. All concurrent&#xD;
      minimally invasive pelvic reconstructive surgical procedures are allowed. Randomization will&#xD;
      be stratified for minimally invasive (robotic or laparoscopic) versus vaginal surgery.&#xD;
&#xD;
      Perioperative care is standardized.&#xD;
&#xD;
      Participants will be scheduled for a post-operative follow up visit at approximately 6 weeks.&#xD;
      At this visit they will have a structured postoperative interview and pelvic examination,&#xD;
      including POP-Q, standardized assessment of suture burden and myofascial trigger points. They&#xD;
      will also complete a VAS and validated questionnaires. Participants will be called at&#xD;
      approximately 6 months after their original surgery. They will have a structured interview&#xD;
      and complete VAS and complete validated questionnaires.&#xD;
&#xD;
      Adverse postoperative outcomes will be collected at each visit.&#xD;
&#xD;
      Investigators will use a standard deviation estimate of 23.4mm to detect a difference on a&#xD;
      100mm VAS for pain. Accounting for a 15% drop-out rate, the investigators aim to enroll 64&#xD;
      participants with 32 in each group.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 14, 2020</start_date>
  <completion_date type="Anticipated">March 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">October 22, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post-operative posterior compartment pain scores</measure>
    <time_frame>6-weeks</time_frame>
    <description>To compare delayed absorbable barbed suture versus non-barbed delayed absorbable suture at the time of posterior repair on post-operative posterior compartment pain scores, as measured by the Visual Analog Scale (VAS).The VAS is a validated scale that is ranges from 0-100mm. 0mm is equivalent to &quot;no pain&quot; and is located on the left. 100mm is equivalent to &quot;worst possible pain&quot; and is located on the right.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Post-operative posterior compartment pain scores</measure>
    <time_frame>6-months</time_frame>
    <description>To compare visual analog scale (VAS) pain scores in the posterior compartment. The VAS is a validated scale that is ranges from 0-100mm. 0mm is equivalent to &quot;no pain&quot; and is located on the left. 100mm is equivalent to &quot;worst possible pain&quot; and is located on the right.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Operative time</measure>
    <time_frame>6-weeks</time_frame>
    <description>To evaluate operative time for posterior repair in minutes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative suture burden</measure>
    <time_frame>6-weeks</time_frame>
    <description>To evaluate suture burden and pelvic pain on examination of the posterior by compartment number by measuring total amount of delayed absorbable suture used for posterior colporrhaphy in cm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in bowel function</measure>
    <time_frame>6-weeks, 6-months</time_frame>
    <description>To evaluate change in bowel function using the Pelvic Floor Distress Inventory- 20 (PFDI-20) sub-scale Colorectal-Anal Distress Inventory-8 (CRADI-8). Total score is obtained by the mean value of all of the answered items within the corresponding scale (possible value 0 to 4). Score can range from 0-80. Then multiply by 25 to obtain the scale score (range 0 to 100). The higher the score the more distress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in pelvic organ prolapse symptoms</measure>
    <time_frame>6-weeks, 6-months</time_frame>
    <description>To evaluate change in pelvic organ prolapse symptoms using the Pelvic Floor Distress Inventory- 20 (PFDI-20) sub-scale the Pelvic Organ Prolapse Distress Inventory- 6 (POPDI-6). Total score is obtained by the mean value of all of the answered items within the corresponding scale (possible value 0 to 4). The score can range from 0-80. Then multiply by 25 to obtain the scale score (range 0 to 100). The higher the score the more distress.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in postoperative sexual function</measure>
    <time_frame>6-months</time_frame>
    <description>To evaluate postoperative sexual function using the Pelvic Organ Prolapse-Urinary Incontinence Sexual Function Questionnaire (PISQ-12). Score is obtained from 0-48. To compare to the long form of the PSIQ, multiple the total score by 2.58. A lower score is associated with poorer sexual function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in cost of delayed absorbable sutures</measure>
    <time_frame>6-weeks</time_frame>
    <description>To evaluate cost of delayed absorbable suture choice based on sutures used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with anatomic failure</measure>
    <time_frame>6 weeks</time_frame>
    <description>To evaluate anatomical failure of posterior compartment using a standard definition of anatomical cure will be defined as Ba or Bp at &lt;/= 0 on POP-Q examination (i.e.at or beyond hymenal ring)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with subjective failure</measure>
    <time_frame>6-weeks, 6-months</time_frame>
    <description>To evaluate subjective failure of posterior compartment using a negative response on POPDI-6 portion of the PFDI-20 questionnaire to questions: &quot;Do you usually have a sensation of bulging or protrusion from the vaginal area?&quot; and &quot;Do you usually have a bulge or something falling out that you can see or feel in the vaginal area?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients with adverse outcomes</measure>
    <time_frame>6-weeks, 6-months</time_frame>
    <description>To evaluate differences in adverse outcomes using modified Clavien-Dindo classification system</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">64</enrollment>
  <condition>Rectocele</condition>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Receives posterior colporrhaphy closure using standardized technique with 2-0 V-Loc 90TM, Medtronic</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Receives posterior colporrhaphy closure using standardized technique with conventional 2-0 PDSÂ® Ethicon</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2-0 dioxanone, glycolide and trimethylene carbonate</intervention_name>
    <description>delayed absorbable, monofilament barbed suture</description>
    <arm_group_label>Intervention</arm_group_label>
    <other_name>2-0 V-Loc 90TM (Medtronic)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>2-0 polydioxanone</intervention_name>
    <description>delayed absorbable, monofilament non-barbed suture</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>2-0 PDSÂ® (Ethicon)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Women&#xD;
&#xD;
          -  Age 18yo or older&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  Planned posterior colporrhaphy with or without perineorrhaphy with concomitant&#xD;
             surgical procedures allowed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Documented allergy or contraindication to use of suture material&#xD;
&#xD;
          -  Prior mesh in posterior compartment&#xD;
&#xD;
          -  Planned colpocleisis&#xD;
&#xD;
          -  Current or prior rectovaginal fistula&#xD;
&#xD;
          -  Planned sacrospinous ligament fixation procedure&#xD;
&#xD;
          -  Chronic pelvic pain diagnosis&#xD;
&#xD;
          -  Chronic narcotic medication use&#xD;
&#xD;
          -  Active vulvodynia&#xD;
&#xD;
          -  Non-English speaking&#xD;
&#xD;
          -  Inability to provide informed consent&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>This study involves women undergoing surgery for pelvic organ prolapse.</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Amanda L Merriman, MD</last_name>
    <phone>704-304-1160</phone>
    <email>amanda.merriman@atriumhealth.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kelly A Kaczmarski, RN</last_name>
    <phone>704-355-4891</phone>
    <email>kelley.kaczmarski@atriumhealth.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Atrium Health</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28207</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda L Merriman, MD</last_name>
      <phone>704-304-1160</phone>
      <email>amanda.merriman@atriumhealth.org</email>
    </contact>
    <contact_backup>
      <last_name>Kelley A Kaczmarski, RN</last_name>
      <phone>704-770-5813</phone>
      <email>kelly.kaczmarski@atriumhealth.org</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Jones KA, Shepherd JP, Oliphant SS, Wang L, Bunker CH, Lowder JL. Trends in inpatient prolapse procedures in the United States, 1979-2006. Am J Obstet Gynecol. 2010 May;202(5):501.e1-7. doi: 10.1016/j.ajog.2010.01.017. Epub 2010 Mar 11.</citation>
    <PMID>20223444</PMID>
  </reference>
  <reference>
    <citation>Kahn MA, Stanton SL. Posterior colporrhaphy: its effects on bowel and sexual function. Br J Obstet Gynaecol. 1997 Jan;104(1):82-6.</citation>
    <PMID>8988702</PMID>
  </reference>
  <reference>
    <citation>Karjalainen PK, Mattsson NK, Nieminen K, Tolppanen AM, Jalkanen JT. The relationship of defecation symptoms and posterior vaginal wall prolapse in women undergoing pelvic organ prolapse surgery. Am J Obstet Gynecol. 2019 Nov;221(5):480.e1-480.e10. doi: 10.1016/j.ajog.2019.05.027. Epub 2019 May 22.</citation>
    <PMID>31128111</PMID>
  </reference>
  <reference>
    <citation>Paraiso MF, Barber MD, Muir TW, Walters MD. Rectocele repair: a randomized trial of three surgical techniques including graft augmentation. Am J Obstet Gynecol. 2006 Dec;195(6):1762-71.</citation>
    <PMID>17132479</PMID>
  </reference>
  <reference>
    <citation>Komesu YM, Rogers RG, Kammerer-Doak DN, Barber MD, Olsen AL. Posterior repair and sexual function. Am J Obstet Gynecol. 2007 Jul;197(1):101.e1-6.</citation>
    <PMID>17618777</PMID>
  </reference>
  <reference>
    <citation>Mowat A, Maher D, Baessler K, Christmann-Schmid C, Haya N, Maher C. Surgery for women with posterior compartment prolapse. Cochrane Database Syst Rev. 2018 Mar 5;3:CD012975. doi: 10.1002/14651858.CD012975. Review.</citation>
    <PMID>29502352</PMID>
  </reference>
  <reference>
    <citation>Evans SKL, Abimbola O, Myers EM, Tarr ME. A Novel Injection Technique for Extended-Release Local Anesthetic After Posterior Colporrhaphy and Perineorrhaphy: A Randomized Controlled Study. Female Pelvic Med Reconstr Surg. 2021 Jun 1;27(6):344-350. doi: 10.1097/SPV.0000000000000855.</citation>
    <PMID>32384288</PMID>
  </reference>
  <reference>
    <citation>Luck AM, Galvin SL, Theofrastous JP. Suture erosion and wound dehiscence with permanent versus absorbable suture in reconstructive posterior vaginal surgery. Am J Obstet Gynecol. 2005 May;192(5):1626-9.</citation>
    <PMID>15902168</PMID>
  </reference>
  <reference>
    <citation>Madhuvrata P, Glazener C, Boachie C, Allahdin S, Bain C. A randomised controlled trial evaluating the use of polyglactin (Vicryl) mesh, polydioxanone (PDS) or polyglactin (Vicryl) sutures for pelvic organ prolapse surgery: outcomes at 2 years. J Obstet Gynaecol. 2011 Jul;31(5):429-35. doi: 10.3109/01443615.2011.576282.</citation>
    <PMID>21627429</PMID>
  </reference>
  <reference>
    <citation>Allahdin S, Glazener C, Bain C. A randomised controlled trial evaluating the use of polyglactin mesh, polydioxanone and polyglactin sutures for pelvic organ prolapse surgery. J Obstet Gynaecol. 2008 May;28(4):427-31. doi: 10.1080/01443610802150077.</citation>
    <PMID>18604681</PMID>
  </reference>
  <reference>
    <citation>Bergman I, SÃ¶derberg MW, Kjaeldgaard A, Ek M. Does the choice of suture material matter in anterior and posterior colporrhaphy? Int Urogynecol J. 2016 Sep;27(9):1357-65. doi: 10.1007/s00192-016-2981-0. Epub 2016 Mar 2.</citation>
    <PMID>26935306</PMID>
  </reference>
  <reference>
    <citation>Greenberg JA, Clark RM. Advances in suture material for obstetric and gynecologic surgery. Rev Obstet Gynecol. 2009 Summer;2(3):146-58.</citation>
    <PMID>19826572</PMID>
  </reference>
  <reference>
    <citation>Greenberg JA, Goldman RH. Barbed suture: a review of the technology and clinical uses in obstetrics and gynecology. Rev Obstet Gynecol. 2013;6(3-4):107-15. Review.</citation>
    <PMID>24920976</PMID>
  </reference>
  <reference>
    <citation>Iavazzo C, Mamais I, Gkegkes ID. The Role of Knotless Barbed Suture in Gynecologic Surgery: Systematic Review and Meta-Analysis. Surg Innov. 2015 Oct;22(5):528-39. doi: 10.1177/1553350614554235. Epub 2014 Oct 15. Review.</citation>
    <PMID>25320107</PMID>
  </reference>
  <reference>
    <citation>Chamsy D, King C, Lee T. The use of barbed suture for bladder and bowel repair. J Minim Invasive Gynecol. 2015 May-Jun;22(4):648-52. doi: 10.1016/j.jmig.2015.01.030. Epub 2015 Feb 7.</citation>
    <PMID>25659867</PMID>
  </reference>
  <reference>
    <citation>Wiggins T, Majid MS, Markar SR, Loy J, Agrawal S, Koak Y. Benefits of barbed suture utilisation in gastrointestinal anastomosis: a systematic review and meta-analysis. Ann R Coll Surg Engl. 2020 Feb;102(2):153-159. doi: 10.1308/rcsann.2019.0106. Epub 2019 Sep 11.</citation>
    <PMID>31508982</PMID>
  </reference>
  <reference>
    <citation>Maher CF, Qatawneh AM, Baessler K, Schluter PJ. Midline rectovaginal fascial plication for repair of rectocele and obstructed defecation. Obstet Gynecol. 2004 Oct;104(4):685-9.</citation>
    <PMID>15458886</PMID>
  </reference>
  <reference>
    <citation>Christmann-Schmid C, Wierenga AP, Frischknecht E, Maher C. A Prospective Observational Study of the Classification of the Perineum and Evaluation of Perineal Repair at the Time of Posterior Colporrhaphy. Female Pelvic Med Reconstr Surg. 2016 Nov/Dec;22(6):453-459.</citation>
    <PMID>27636214</PMID>
  </reference>
  <reference>
    <citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009 Apr;42(2):377-81. doi: 10.1016/j.jbi.2008.08.010. Epub 2008 Sep 30.</citation>
    <PMID>18929686</PMID>
  </reference>
  <reference>
    <citation>Crisp CC, Bandi S, Kleeman SD, Oakley SH, Vaccaro CM, Estanol MV, Fellner AN, Pauls RN. Patient-controlled versus scheduled, nurse-administered analgesia following vaginal reconstructive surgery: a randomized trial. Am J Obstet Gynecol. 2012 Nov;207(5):433.e1-6. doi: 10.1016/j.ajog.2012.06.040. Epub 2012 Jun 20.</citation>
    <PMID>22863282</PMID>
  </reference>
  <reference>
    <citation>Barber MD, Brubaker L, Nygaard I, Wheeler TL 2nd, Schaffer J, Chen Z, Spino C; Pelvic Floor Disorders Network. Defining success after surgery for pelvic organ prolapse. Obstet Gynecol. 2009 Sep;114(3):600-609. doi: 10.1097/AOG.0b013e3181b2b1ae.</citation>
    <PMID>19701041</PMID>
  </reference>
  <reference>
    <citation>Bodian CA, Freedman G, Hossain S, Eisenkraft JB, Beilin Y. The visual analog scale for pain: clinical significance in postoperative patients. Anesthesiology. 2001 Dec;95(6):1356-61.</citation>
    <PMID>11748392</PMID>
  </reference>
  <reference>
    <citation>Jensen MP, Chen C, Brugger AM. Interpretation of visual analog scale ratings and change scores: a reanalysis of two clinical trials of postoperative pain. J Pain. 2003 Sep;4(7):407-14.</citation>
    <PMID>14622683</PMID>
  </reference>
  <reference>
    <citation>Lee JS, Hobden E, Stiell IG, Wells GA. Clinically important change in the visual analog scale after adequate pain control. Acad Emerg Med. 2003 Oct;10(10):1128-30.</citation>
    <PMID>14525749</PMID>
  </reference>
  <reference>
    <citation>Westermann LB, Crisp CC, Mazloomdoost D, Kleeman SD, Pauls RN. Comparative Perioperative Pain and Recovery in Women Undergoing Vaginal Reconstruction Versus Robotic Sacrocolpopexy. Female Pelvic Med Reconstr Surg. 2017 Mar/Apr;23(2):95-100. doi: 10.1097/SPV.0000000000000368.</citation>
    <PMID>28067743</PMID>
  </reference>
  <reference>
    <citation>Meister MR, Sutcliffe S, Ghetti C, Chu CM, Spitznagle T, Warren DK, Lowder JL. Development of a standardized, reproducible screening examination for assessment of pelvic floor myofascial pain. Am J Obstet Gynecol. 2019 Mar;220(3):255.e1-255.e9. doi: 10.1016/j.ajog.2018.11.1106. Epub 2018 Dec 7.</citation>
    <PMID>30527941</PMID>
  </reference>
  <reference>
    <citation>He S, Falk K, Kannan A, Kelley RS. An Alternative Approach to Posterior Colporrhaphy Plication Using Delayed Absorbable Unidirectional Barbed Suture. Female Pelvic Med Reconstr Surg. 2020 Feb;26(2):107-110. doi: 10.1097/SPV.0000000000000828.</citation>
    <PMID>31990797</PMID>
  </reference>
  <reference>
    <citation>Culligan PJ. Surgical repair of the posterior compartment. Clin Obstet Gynecol. 2005 Sep;48(3):704-12. Review.</citation>
    <PMID>16012237</PMID>
  </reference>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>November 19, 2020</study_first_submitted>
  <study_first_submitted_qc>December 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">December 8, 2020</study_first_posted>
  <last_update_submitted>September 20, 2021</last_update_submitted>
  <last_update_submitted_qc>September 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atrium Health</investigator_affiliation>
    <investigator_full_name>Amanda Merriman</investigator_full_name>
    <investigator_title>FPMRS Fellow, Junior Faculty</investigator_title>
  </responsible_party>
  <keyword>pelvic organ prolapse</keyword>
  <keyword>barbed suture</keyword>
  <keyword>posterior colporrhaphy</keyword>
  <keyword>posterior repair</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectocele</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cyclopropane</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

